Breast Cancer Trial, Not Yet Recruiting NCT06910280 Sponsor: Centre Hospitalier Universitaire de Besancon Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT06910280
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 years or older
  • People who have been diagnosed with invasive breast cancer, confirmed by a tissue sample (biopsy) from the breast
  • People whose tumor is a certain size or smaller, based on standard breast cancer measurements (known as clinical T2 or smaller)
  • People with no signs — from physical examination or scans — that the cancer has spread to the lymph nodes
  • People who are enrolled in, or covered by, the French social security system
  • People whose case has been reviewed and approved by a specialist medical team (multidisciplinary tumor board) for breast-conserving surgery combined with a sentinel lymph node biopsy
  • People who have read and signed an informed consent form, showing they understand what the study involves and agree to take part and follow its requirements

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a BMI strictly above 35 (classified as severe or morbid obesity)
  • People with a BMI strictly below 18.5 (classified as underweight/emaciation)
  • People for whom the medications used in this study are medically unsuitable
  • People for whom general anaesthesia is medically unsuitable
  • People for whom the local anaesthesia approach used in this study is medically unsuitable
  • People whose tumor the surgeon assesses as unable to be removed under local anaesthesia
  • People whose cancer appears in two separate areas of the breast (bifocal tumor)
  • People who would require additional reconstructive breast surgery as part of their procedure
  • People who would need a surgical procedure on the other breast at the same time (such as a port placement, breast lift, or mastectomy)
  • People who withdrew their consent before surgery took place
  • People who do not have full legal capacity to make their own decisions
  • People who are not fluent in French, or where the investigator anticipates there may be significant difficulty understanding the study
  • People who do not have health insurance coverage
  • People who are pregnant
  • People who are currently in an exclusion period from another clinical study, or who are listed in the national volunteer registry

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Besancon
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 August 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluate the overall feasibility of a prospective randomized two-arm protocol: 'Local Anesthesia' and 'General Anesthesia' in the context of partial mastectomy combined with sentinel lymph node study.; Evaluate the overall feasibility of a prospective randomized two-arm protocol: 'Local Anesthesia' and 'General Anesthesia' in the context of partial mastectomy combined with sentinel lymph node study.; Evaluate the overall feasibility of a prospective randomized two-arm protocol: 'Local Anesthesia' and 'General Anesthesia' in the context of partial mastectomy combined with sentinel lymph node st...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov